866-997-4948(US-Canada Toll Free)

Published on : Jan 22, 2016

According to the World Health Organization (WHO), an estimated 15% of adults aged 60 and above suffer from mental disorders across the globe. Dementia and depression are the most common public health issues among the elderly. According to a recent report released by New York city’s Department of Health and Mental Hygiene, at least one in five adults in the city suffer from depression, suicidal thoughts, and other psychological disorders. With an ever growing demand for efficient and robust mental healthcare services, the global mental health software market is expected to flourish in the near future. 

Understanding the importance of the role of technology in treating mental disorders, the United Kingdom’s National Health Service has launched a series of seven trials with several major technology partners. The pilot project is aimed at integrating med-tech into at-home care for the elderly and patients suffering from chronic diseases. The partnership between the NHS, Verily, and MSD will determine the feasibility of the usage of data analysis technology in managing, detecting, and preventing diseases. Verily is part of the Alphabet corporate umbrella and was previously known as Google Life Sciences. 

Among the clinical trials with some of the key players in the technology sector include a mental health digital tool test with Accenture that will offer risk assessments, online support, predictive analytics, and crisis intervention plans in Solihull and Birmingham. Another healthy aging trial in North East London will use technology from Health Analytics, UCLPartners, Orion Health and nine other undisclosed participants to better enable participants to manage health conditions and to remain as independent as possible. It will evaluate an online tool for people with dementia, a peer-to-peer social network app and a device that assesses fall risk and mobility.